- Latest Headlines
- ‘Tis the Season … to Shop for a Good Cause!
- Imaging Services a National Case Study for Maintaining CT Image Quality While Lowering Radiation Dose
- Download the Early Childhood Direction Center Winter 2013 Newsletter
- VNA of WNY Ranked Among Top Five Percent Nationally
- Millard Fillmore Suburban Hospital Respiratory Team Receives Elite Distinction
- View All Headlines
- Kaleida in the News
- Media Advisories
- Press Releases
- Facts at a Glance
- KYI Newsletter
726 Exchange Street
Buffalo, NY 14210
Dr. Quattrin is a Leading Researcher for Major Grant to Study Potential Treatment for Type 1 Diabetes
Teresa Quattrin, M.D., Pediatrician-in-Chief, Women & Children's Hospital of Buffalo, and Professor of Pediatrics, Chair, Department of Pediatrics, University of New York at Buffalo, is a leading researcher for a $600,000 grant awarded by the American Diabetes Association to further a pilot study conducted that found that a drug used to treat Type 2 diabetes could also help Type 1 diabetics.
If the initial findings on liraglutide are confirmed in the larger study, it could mean the first significant new treatment for Type 1 diabetes since insulin’s discovery in the 1920s.
|Related Kaleida Service: Endocrinology/Diabetes|